Radiology leaders are urged to understand forthcoming CMS 2026 reimbursement changes for CCTA, FFR-CT, and AI plaque analysis.
Key Details
- 1CMS 2026 Final Rule will alter reimbursement for CCTA, FFR-CT, and AI-enabled plaque analysis.
- 2A new Category 1 code for AI-Enabled Coronary Plaque Analysis will be introduced.
- 3Webinar to educate on payment policies, projected 2026 rates, and integration of advanced analytics.
- 4Guidance provided on operational best practices, revenue codes, and managing prior authorization.
- 5Aimed at imaging administrators, coding specialists, and radiology service leaders preparing for policy shifts.
Why It Matters
These reimbursement changes will impact clinical workflows, financial planning, and access to innovative cardiac imaging technologies for radiology providers. Proactive adaptation will be key to maintaining service viability and quality care.
Source
Radiology Business
Related News
•Radiology Business
FDA Clears Median's Eyonis AI for CT Lung Cancer Screening
Median Technologies' Eyonis LCS, an AI tool for low-dose CT lung cancer screening, receives FDA clearance.
•AuntMinnie
Deep Learning Super-Resolution Boosts Accuracy of Coronary CT Angiography
Super-resolution deep learning reconstruction (SR-DLR) outperforms hybrid iterative reconstruction in coronary CT angiography for stenosis assessment.
•Radiology Business
Medicare May Deny Coverage for AI-Based Brain MRI Tools
A Medicare contractor has proposed denying coverage for AI tools used in brain MRI analysis, citing insufficient evidence and data limitations.